JP2022501434A5 - - Google Patents
Info
- Publication number
- JP2022501434A5 JP2022501434A5 JP2021539498A JP2021539498A JP2022501434A5 JP 2022501434 A5 JP2022501434 A5 JP 2022501434A5 JP 2021539498 A JP2021539498 A JP 2021539498A JP 2021539498 A JP2021539498 A JP 2021539498A JP 2022501434 A5 JP2022501434 A5 JP 2022501434A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- bcl
- inhibitor
- agent according
- combination agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732816P | 2018-09-18 | 2018-09-18 | |
| US62/732,816 | 2018-09-18 | ||
| PCT/US2019/051764 WO2020061216A1 (en) | 2018-09-18 | 2019-09-18 | Combination therapy for treating blood cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501434A JP2022501434A (ja) | 2022-01-06 |
| JP2022501434A5 true JP2022501434A5 (enExample) | 2022-09-28 |
| JP7460639B2 JP7460639B2 (ja) | 2024-04-02 |
Family
ID=68104787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539498A Active JP7460639B2 (ja) | 2018-09-18 | 2019-09-18 | 血液癌を治療するための併用療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12097194B2 (enExample) |
| EP (1) | EP3852766B1 (enExample) |
| JP (1) | JP7460639B2 (enExample) |
| KR (1) | KR102764125B1 (enExample) |
| CN (1) | CN112739349B (enExample) |
| AU (1) | AU2019343044B2 (enExample) |
| BR (1) | BR112021005054A2 (enExample) |
| CA (1) | CA3110901C (enExample) |
| IL (1) | IL281439B2 (enExample) |
| MX (1) | MX2021003062A (enExample) |
| SG (1) | SG11202101955SA (enExample) |
| TW (1) | TWI824010B (enExample) |
| WO (1) | WO2020061216A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| IL316472A (en) | 2018-01-10 | 2024-12-01 | Recurium Ip Holdings Llc | Benzamide compounds |
| CN114727974A (zh) | 2019-07-30 | 2022-07-08 | 艾科尼佐治疗股份有限公司 | Hdac6抑制剂及其用途 |
| EP4054585A1 (en) | 2019-11-05 | 2022-09-14 | Abbvie Inc. | Dosing regimens for use in treating myelofibrosis and mpn-related disorders with navitoclax |
| WO2022169985A1 (en) | 2021-02-03 | 2022-08-11 | Eikonizo Therapeutics, Inc. | Hdac6 inhibitors and uses thereof |
| AU2023250964A1 (en) | 2022-04-08 | 2024-11-07 | Eikonizo Therapeutics, Inc. | Oxadiazole hdac6 inhibitors and uses thereof |
| TW202545523A (zh) * | 2024-02-05 | 2025-12-01 | 加拿大商聖諾康生命科學公司 | 用於治療血液癌症之組合療法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7973161B2 (en) * | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| ES2493466T3 (es) | 2005-05-12 | 2014-09-11 | Abbvie Bahamas Ltd. | Promotores de la apoptosis |
| BRPI1007046B1 (pt) | 2009-01-16 | 2019-07-16 | Rigel Pharmaceuticals, Inc. | Inibidores axl para uso em terapia de combinação para evitar, tratar ou controlar o câncer metastático. |
| RU2593231C2 (ru) | 2010-11-23 | 2016-08-10 | ЭббВи Айэленд Анлимитед Компани | Способы лечения с использованием селективных ингибиторов bcl-2 |
| WO2014020043A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
| JP6496731B2 (ja) * | 2013-11-27 | 2019-04-03 | シグナルケム・ライフサイエンシーズ・コーポレイションＳｉｇｎａｌｃｈｅｍ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｔａｍファミリーキナーゼ阻害剤としてのアミノピリジン誘導体 |
| US9993472B2 (en) * | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
| US20170137426A1 (en) * | 2014-03-28 | 2017-05-18 | Changzhou Jiekai Pharmatech Co., Ltd. | Heterocyclic compounds as axl inhibitors |
-
2019
- 2019-09-18 TW TW108133696A patent/TWI824010B/zh active
- 2019-09-18 JP JP2021539498A patent/JP7460639B2/ja active Active
- 2019-09-18 AU AU2019343044A patent/AU2019343044B2/en active Active
- 2019-09-18 BR BR112021005054-0A patent/BR112021005054A2/pt unknown
- 2019-09-18 CA CA3110901A patent/CA3110901C/en active Active
- 2019-09-18 KR KR1020217009727A patent/KR102764125B1/ko active Active
- 2019-09-18 US US17/276,459 patent/US12097194B2/en active Active
- 2019-09-18 EP EP19780095.6A patent/EP3852766B1/en active Active
- 2019-09-18 SG SG11202101955SA patent/SG11202101955SA/en unknown
- 2019-09-18 MX MX2021003062A patent/MX2021003062A/es unknown
- 2019-09-18 IL IL281439A patent/IL281439B2/en unknown
- 2019-09-18 WO PCT/US2019/051764 patent/WO2020061216A1/en not_active Ceased
- 2019-09-18 CN CN201980060442.6A patent/CN112739349B/zh active Active